Study to Evaluate Pharmacokinetics, Safety and Tolerability of Dolutegravir and Rilpivirine (JULUCA™) 50 Milligram (mg)/25 mg Tablets in Healthy Subjects of Japanese Descent
Condition(s):HIV InfectionsLast Updated:July 14, 2020Completed
Hide Studies Not Open or Pending
Condition(s):HIV InfectionsLast Updated:July 14, 2020Completed
Condition(s):HIV InfectionsLast Updated:August 25, 2023Completed
Condition(s):Infection, Human Immunodeficiency VirusLast Updated:June 27, 2016Completed
Condition(s):Infections, Human Immunodeficiency Virus and HepatitisLast Updated:October 15, 2012Completed
Condition(s):HIV/AIDS; ESRDLast Updated:September 28, 2023Completed
Condition(s):HIV InfectionsLast Updated:May 11, 2023Not yet recruiting
Condition(s):Infection, Human Immunodeficiency Virus; HIV InfectionsLast Updated:July 15, 2019Completed
Condition(s):Hiv; HIV Infections; HIV-1-infection; Paediatric Human Immunodeficiency Virus InfectionLast Updated:February 9, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.